Tag: lipid management

1 Month of DAPT Inadequate After Recent ACS

One month of dual antiplatelet therapy (DAPT) followed by 11 months of clopidogrel monotherapy failed to prove noninferiority to 12 unbroken months of DAPT for...

Tackle Obesity to Drop Risk for Secondary Cardiac Event

Patients who had been hospitalized for heart attack or cardiovascular revascularization procedures commonly were overweight (46%) or had obesity (35%), but at a follow-up visit,...

Hospital Intervention Fails to Improve Heart Failure Outcomes

A clinical trial of an intervention designed to improve outcomes for patients hospitalized with heart failure shows that the strategy was not successful compared to...

Cognitive Deficits Linked to CV Risk Factors in Diabetes

In type 2 diabetes (T2D), a greater degree of hyperlipidemia and hypertension, although not hyperglycemia, was associated with measurable cognitive impairment even among patients with...

Younger Adults With HIV Have Higher CVD Risk but Low ASCVD Scores

People age 40 and younger living with HIV have a higher risk for heart disease than even their over-40 peers living with HIV — and...

CTA May Guide Primary Prevention Statins in Nonobstructive CAD

The relative risk of death or myocardial infarction (MI) went down with statin therapy in a cohort study of patients with either nonobstructive coronary artery...

Ticagrelor Beneficial for Moderate Stroke: New THALES Analysis

For patients with a moderate-size stroke, benefit from ticagrelor plus aspirin was the same as for patients with minor stroke, a new exploratory analysis of...

AHS Releases Updated Guidance on New Migraine Treatments

An updated consensus statement from the American Headache Society (AHS) offers detailed recommendations on the use of novel acute and preventive treatments in adult patients...

South Asian Ancestry Linked to Increased Risk for Heart Disease

Individuals of South Asian ancestry face twice the risk of heart disease, compared with individuals of European descent, yet existing risk calculators fail to account...

Cardiology Journal Flags Papers Cited Hundreds of Times

A European cardiology journal has issued expressions of concern for seven widely-cited papers dating back to 2009 after a reader flagged suspicious images in the...

No Sequelae From Lab Abnormalities in Isotretinoin Study

Isotretinoin use contributed to abnormal lipid lab values in pediatric patients, but no secondary effects were observed, results from a single-center retrospective study demonstrated. “Isotretinoin...

Diet High in Fat, Fried Foods Linked to Sudden Cardiac Death

A large study shows that eating a diet high in fat, fried foods, processed meats, and sugary drinks is linked to a higher risk of...

No Overall Statin Effect Seen on Dementia, Cognition

Statin therapy likely didn’t lead to dementia or even mild cognitive impairment (MCI) in older patients taking the drugs for cardiovascular (CV) primary prevention in...

A1c Below Prediabetes Cutoff Linked to Subclinical Atherosclerosis

Hemoglobin A1c above 5% but below the prediabetes cutoff of 5.5% is an additional potential biomarker of subclinical atherosclerosis in people with low cardiovascular disease...

LDCT Lung Cancer Screening May ID Aortic Stenosis Risk

Using low-dose computed tomography (LDCT) to screen for aortic valve calcification during a lung cancer screening could identify those at risk for aortic stenosis, says...

Lipoprotein Apheresis Shows Durable Impact on CV Outcomes

Lipoprotein apheresis (LA) is a safe and effective treatment for very-high-risk dyslipidemia, sustainably reducing cholesterol and lipoprotein levels to within target levels and markedly lowering...

Aerobic Training Boosts the Power of Antihypertensive Drugs

Aerobic exercise augments the blood pressure-lowering effect of antihypertensive medication in hypertensive individuals with metabolic syndrome. In a small study, these patients experienced a greater...

Genotype-Guided Antiplatelet Therapy Misses Mark

The observational extended study of the previously reported 12-month randomized TAILOR-PCI trial shows genotype-guided antiplatelet therapy after percutaneous coronary intervention (PCI) did not significantly reduce...

Do Anti-ApoA-1 Antibodies Link Fatty Liver Disease and CVD?

Anti-apolipoprotein A-1 (ApoA-1) antibodies are common in non-alcoholic fatty liver disease (NAFLD) and may not only drive its development but also underlie the link between...

Limited-Variant Screening Tests Often Miss Familial Hypercholesterolemia

NEW YORK (Reuters Health) – Two-thirds of cases of familial hypercholesterolemia (FH) would be missed by relying on array-based genetic tests that screen for only...

BP Lowering Useful in CV Risk Management Even at Normal Levels

Lowering blood pressure with antihypertensive medication protects against future cardiovascular (CV) events even in people with normal or only mildly elevated blood pressure, a large...

New AHA Guidance on Obesity and Cardiovascular Risk

An updated American Heart Association scientific statement on the role of obesity in cardiovascular disease provides the first new guidance in 15 years, drawing on...

Arthritis Drug May Curb Myocardial Damage in Acute STEMI

Early use of tocilizumab (Actemra) does not reduce myocardial infarct size but modestly increases myocardial salvage in patients with acute ST-segment elevation myocardial infarction (STEMI),...

OCS Heart System Earns Hard-Won Backing of FDA Panel

After more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support to a premarket approval application...

Vasodilatory Medications Found Protective Against Rosacea

Vasodilators may have a protective effect against rosacea, results from a single-center retrospective cohort study showed. “Our initial hypothesis was that perhaps antihypertensive agents might...